Kolexia
Combe-Marzelle Sophie Médecine générale
Combe-Marzelle Sophie
Médecine générale
Hôpital Cochin
Paris, France
41 Activités
0 Followers
Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Hémophilie A Maladies de von Willebrand Hémorragie Hémophilie B Embolie pulmonaire Thrombose Complications postopératoires Maladie de von Willebrand de type 2 Thrombasthénie

Collaborateurs

Voir plus
Proulle Valerie
Proulle Valerie
Hôpital Bicêtre, Le Kremlin-Bicêtre, France
Roussel-Robert Valerie
Roussel-Robert Valerie
Hôpital Cochin, Paris, France
Perrier-Cornet Andréas
Perrier-Cornet Andréas
Hôpital Bichat-Claude-Bernard, Paris, France
D'Oiron Roseline
D'Oiron Roseline
Hôpital Bicêtre, Le Kremlin-Bicêtre, France

Industries

Voir plus
A+A
4 collaboration(s)
Dernière en 2022
LFB
3 collaboration(s)
Dernière en 2023
Sobi
3 collaboration(s)
Dernière en 2023
Roche
1 collaboration(s)
Dernière en 2021

Dernières activités

Voir plus
Hémophilie
HAS Publications   20 juin 2023
PO225 ACQUIRED VON WILLEBRAND SYNDROME AND USE OF VONICOG ALPHA: A CASE-REPORT
16th Annual Congress of European Association for Haemophilia and Allied Disorders 2023, 7–10 February 2023, Manchester   05 février 2023
PO158 EFFICACY AND SAFETY OF HIGH RATIO HVWF/FVIII CONCENTRATE (VONCENTO®) FOR THE TREATMENT OF BLEEDING EPISODES IN PATIENTS WITH VON WILLEBRAND DISEASE: THE OPALE FRENCH EXPERIENCE
15th Annual Congress of European Association for Haemophilia and Allied Disorders 2022, 2–4 February 2022, Virtual Meeting   31 janvier 2022
Whole Blood Impedance Aggregometry: A Usefool Tool but Still Not the Gold Standard
Special Issue: Abstracts of the ISTH 2021 Virtual Congress of the International Society of Thrombosis and Haemostasis, July 17–21, 2021   07 octobre 2021
Pharmacodynamics of eftrenonacog-alfa (rFIX-Fc) in severe hemophilia B patients: A real-life study.
European journal of pharmacology   27 novembre 2020
Effectiveness and safety of hFVIII/VWF concentrate (Voncento ) in patients with inherited von Willebrand disease requiring surgical procedures: the OPALE multicentre observational study.
Blood transfusion = Trasfusione del sangue   27 novembre 2020
Monitoring and Pharmacodynamic Effect of Eftrenonacog-Alfa (Alprolix®) in Severe Hemophilia B Patients: A Real-Life Study
Abstracts of the ISTH 2020 Virtual Congress of the International Society on Thrombosis and Haemostasis, July 12–14, 2020   11 août 2020
Successful Non-surgical Management and Use of Thrombopoietin Receptor Agonist in a Case of Spleen Injury in a Young Girl with von Willebrand Disease Type 2B
Abstracts of the XXVII Congress of the International Society on Thrombosis and Haemostasis, July 6–10, 2019   21 juin 2019
Dosage of Factor IX in Persons with Hemophilia B Treated with Recombinant FIX Linked to an IgG Fc Domain: Comparison of 3 Methods in a French Hospital
Abstracts of the XXVII Congress of the International Society on Thrombosis and Haemostasis, July 6–10, 2019   21 juin 2019
FVIII dosages in persons with haemophilia A treated with extended half-life products: From local biology to optimized patient management.
Haemophilia : the official journal of the World Federation of Hemophilia   17 juin 2019